Manipulation of intestinal microbiome as potential treatment for insulin resistance and type 2 diabetes
Eur J Nutr. 2021 Mar 2. doi: 10.1007/s00394-021-02520-4. Online ahead of print. PMID: 33651137 Review.
PURPOSE: Increasing evidence suggests that the intestinal microbiome (IM) and bacterial metabolites may influence glucose homeostasis, energy expenditure and the intestinal barrier integrity and lead to the presence of systemic low-grade inflammation, all of
